American Association for Cancer Research Applauds FDA for Actions to Protect Children from Tobacco-related Disease
New restrictions aimed at halting and reversing the alarming rise in the use of e-cigarettes among youth WASHINGTON, D.C....
New restrictions aimed at halting and reversing the alarming rise in the use of e-cigarettes among youth WASHINGTON, D.C....
PHILADELPHIA and ALEXANDRIA, Va. – The American Association for Cancer Research (AACR) and the American Society of Clinical Oncology...
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the formation of its eighth and newest scientific...
PHILADELPHIA – The American Association for Cancer Research (AACR) is pleased to announce the recipients of the 2024 AACR...
PHILADELPHIA – A HER2-targeted antibody-drug conjugate, fam-trastuzumab deruxtecan-nxki (Enhertu), showed signs of clinical activity in multiple non-breast/non-gastric cancer types,...
PHILADELPHIA – The American Association for Cancer Research (AACR) will award Gordon J. Freeman, PhD, FAACR, with the 2024...
Among patients who received immunotherapy, outcomes were similar between Black and white patients LOS ANGELES – In recent years,...
LOS ANGELES – The Affordable Care Act (ACA) has led to increased guideline-concordant care for colon cancer among non-white...
Disaggregating statistics revealed key differences in ethnic populations ORLANDO, Fla. – An analysis of lung cancer incidence rates showed...
PHILADELPHIA – The American Association for Cancer Research (AACR) will award Steven A. Rosenberg, MD, PhD, Fellow of the...
SAN ANTONIO – Comprehensive profiling of fusion RNAs present in a large cohort of metastatic breast tumors revealed unique...
Most people are also not aware that HPV can cause anal, oral, and penile cancers ORLANDO, Fla. – Americans...
PHILADELPHIA – A study that tracked parental opinion about the human papillomavirus (HPV) vaccine showed that after hesitancy decreased...
PHILADELPHIA – The American Association for Cancer Research (AACR) will honor Chi Van Dang, MD, PhD, Fellow of the...
ORLANDO, Fla. – Genomic profiling of patients who were treated for colorectal cancer at a major U.S. cancer center...
PHILADELPHIA — The American Association for Cancer Research (AACR) will award the 20th AACR-Irving Weinstein Foundation Distinguished Lectureship to...
HPV testing eight years after a negative result instead of the recommended five was found comparable to standard cytology...
More than 350 organizations join forces again this year to improve health, inspire hope, and save lives WASHINGTON, D.C....
Assay can also help identify patients who may benefit from ovarian suppression therapy SAN ANTONIO – Among premenopausal women...
SAN DIEGO – Accelerated aging was more common in recent birth cohorts and was associated with increased incidence of...
The investigational therapy uses a cold-temperature probe to kill a portion of prostate cancer cells and release tumor-specific neoantigens...
Patricia M. LoRusso, DO, PhD (hc), FAACR, begins term as AACR President SAN DIEGO – The members of the...
PHILADELPHIA – Incidence and severity of neurological side effects from chimeric antigen receptor (CAR) T-cell therapy were higher in...
SAN ANTONIO – Patients with multiple tumors in the same breast who underwent a lumpectomy followed by radiation therapy...
PHILADELPHIA – The American Association for Cancer Research (AACR) will award Carl H. June, MD, Fellow of the AACR...
Researchers applied single-nucleus RNA sequencing and spatial transcriptomics to identify potential therapeutic targets in brain metastases ORLANDO, Fla. –...
Cancer patients eligible for precision oncology therapies nearly doubled between 2017 and 2022 PHILADELPHIA – Of the 198 new...
PHILADELPHIA – The frequency of second primary malignancies (SPMs) arising in cancer survivors following treatment with CAR T-cell therapy...
Treatment consisted of high-dose abatacept, ruxolitinib, and proactive monitoring for respiratory muscle involvement PHILADELPHIA – Among cancer patients who...
ORLANDO, Fla. – Compared to the year 2000, a greater proportion of NCI-sponsored early-phase clinical trial participants in 2022...